Literature DB >> 6746465

Two unusual budding bacteria isolated from a swimming pool.

L I Sly, M H Hargreaves.   

Abstract

Two unusual strains of budding bacteria were isolated on a Millipore Pseudomonas Count Water Tester during routine monitoring of Pseudomonas aeruginosa counts in a swimming pool. The first isolate has been identified as Blastobacter sp. It was a yellow-pigmented, Gram negative rod-shaped organism with a polar holdfast by which it attached to solid surfaces or other cells to form rosettes. The cells reproduced by asymmetric division or budding at the free pole of the cell, producing motile daughter cells with a single polar flagellum. The second isolate, which has not yet been identified, was a red-pigmented, Gram negative rod-shaped organism which produced one or more buds at each pole of the cell. Cell division appears to occur by both binary fission and by budding. Both organisms were strict aerobes, catalase and oxidase positive and did not produce acid from glucose in Hugh and Leifson medium.

Entities:  

Mesh:

Year:  1984        PMID: 6746465     DOI: 10.1111/j.1365-2672.1984.tb01376.x

Source DB:  PubMed          Journal:  J Appl Bacteriol        ISSN: 0021-8847


  4 in total

1.  Coaggregation between aquatic bacteria is mediated by specific-growth-phase-dependent lectin-saccharide interactions.

Authors:  A H Rickard; S A Leach; C M Buswell; N J High; P S Handley
Journal:  Appl Environ Microbiol       Date:  2000-01       Impact factor: 4.792

2.  Biotransformation and detoxification of T-2 toxin by soil and freshwater bacteria.

Authors:  S Beeton; A T Bull
Journal:  Appl Environ Microbiol       Date:  1989-01       Impact factor: 4.792

3.  Coaggregation by the freshwater bacterium Sphingomonas natatoria alters dual-species biofilm formation.

Authors:  K R Min; A H Rickard
Journal:  Appl Environ Microbiol       Date:  2009-04-17       Impact factor: 4.792

4.  Bioactive pigments from marine bacteria: applications and physiological roles.

Authors:  Azamjon B Soliev; Kakushi Hosokawa; Keiichi Enomoto
Journal:  Evid Based Complement Alternat Med       Date:  2011-09-26       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.